FT News Briefing cover image

Germany backs EU recovery fund, Gilead drug flops, Rana Foroohar on US austerity

FT News Briefing

00:00

Market Reactions and Early Trial Results for Remdesivir

This chapter explores the accidental publication of early trial results for remdesivir by the World Health Organization and the implications of these findings. It discusses the mixed reactions from Gilead and the stock market, reflecting the heightened sensitivity to the drug's perceived effectiveness.

Play episode from 03:07
Transcript

The AI-powered Podcast Player

Save insights by tapping your headphones, chat with episodes, discover the best highlights - and more!
App store bannerPlay store banner
Get the app